George Abercrombie joins Inspire's board
This article was originally published in Scrip
Inspire Pharmaceuticals (US) has elected George Abercrombie to its board of directors. Mr Abercrombie most recently served as president and CEO of Roche Inc and head of North American pharmaceutical operations from 2001 to December 2009. During this time, he led the North American pharmaceutical operations for the Roche Group in the US and Canada. From 1997 to 2001, Mr Abercrombie was senior vice-president of commercial operations at Glaxo Wellcome.
You may also be interested in...
Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.
FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned about drug and supplements GMP violations and was an easy target for FDA following release of draft guidance outlining its enforcement priorities.
Richard Pazdur, FDA's oncology chief, reiterates the breakthrough therapy designation is for agency-sponsor communication and not an investor tool.